Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4003392 | American Journal of Ophthalmology | 2011 | 13 Pages |
Abstract
This study shows that DALK is more costly and more effective as compared with PK. Results on the 25-item National Eye Institute Visual Functioning Questionnaire were in favor of DALK, and endothelial cell loss in DALK patients remained stable after 6 months, whereas cell loss in PK patients continued. Furthermore, DALK procedures performed without perforation of the Descemet membrane were more effective. However, because it is unknown what society is willing to pay for an additional improved patient, cost effectiveness of DALK within a limited follow-up period of 12 months is unclear. Cost effectiveness of DALK may improve over time because of lower graft failure.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Frank J.H.M. van den Biggelaar, Yanny Y.Y. Cheng, Rudy M.M.A. Nuijts, Jan S. Schouten, Robert-Jan Wijdh, Elisabeth Pels, Hugo van Cleynenbreugel, Catharina A. Eggink, Michel J.W. Zaal, Wilhelmina J. Rijneveld, Carmen D. Dirksen,